Photo for representational purpose only. - File photo
New Delhi, March 27
The Indian Council of Medical Research (ICMR) today said it would back Prevall, the country’s first oral chemotherapy drug for treating acute lymphoblastic leukaemia, the most common type of blood cancer afflicting children. Doctors from Tata Memorial Hospital, Mumbai, and the Advanced Centre for Training Research and Education in Cancer collaborated with IDRS Labs, Bengaluru, and developed the oral suspension of 6-mercaptopurine in India.
The Tribune News Service brings you the latest news, analysis and insights from the region, India and around the world. Follow the Tribune News Service for a wide-ranging coverage of events as they unfold, with perspective and clarity.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Gujarat ATS arrests 4 Sri Lankan nationals with IS links on mission to carry out terror activities
Acting on a tip-off, the ATS apprehendsd the accused at the ...
Heat wave: Punjab announces early summer holidays for government, private schools from May 21
Teaching/non-teaching staff would continue to perform their ...
JD(S) MLA HD Revanna gets bail from Bengaluru court in sexual assault case
Judge Preeth J refused to hear objections from SIT and order...
Govt announces state mourning on May 21 for Iranian President Ebrahim Raisi
Raisi died in a helicopter crash
